167 related articles for article (PubMed ID: 21597995)
1. PCDH10 is a candidate tumour suppressor gene in medulloblastoma.
Bertrand KC; Mack SC; Northcott PA; Garzia L; Dubuc A; Pfister SM; Rutka JT; Weiss WA; Taylor MD
Childs Nerv Syst; 2011 Aug; 27(8):1243-9. PubMed ID: 21597995
[TBL] [Abstract][Full Text] [Related]
2. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
Qiu C; Bu X; Jiang Z
Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
[TBL] [Abstract][Full Text] [Related]
3. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
[TBL] [Abstract][Full Text] [Related]
4. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
7. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.
Narayan G; Scotto L; Neelakantan V; Kottoor SH; Wong AH; Loke SL; Mansukhani M; Pothuri B; Wright JD; Kaufmann AM; Schneider A; Arias-Pulido H; Tao Q; Murty VV
Genes Chromosomes Cancer; 2009 Nov; 48(11):983-92. PubMed ID: 19681120
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.
Nakahara Y; Northcott PA; Li M; Kongkham PN; Smith C; Yan H; Croul S; Ra YS; Eberhart C; Huang A; Bigner D; Grajkowska W; Van Meter T; Rutka JT; Taylor MD
Neoplasia; 2010 Jan; 12(1):20-7. PubMed ID: 20072650
[TBL] [Abstract][Full Text] [Related]
9. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
[TBL] [Abstract][Full Text] [Related]
10. PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.
Narayan G; Xie D; Freddy AJ; Ishdorj G; Do C; Satwani P; Liyanage H; Clark L; Kisselev S; Nandula SV; Scotto L; Alobeid B; Savage D; Tycko B; O'Connor OA; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2013 Nov; 52(11):1030-41. PubMed ID: 23929756
[TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer.
Zhong X; Zhu Y; Mao J; Zhang J; Zheng S
J Cancer Res Clin Oncol; 2013 Mar; 139(3):485-90. PubMed ID: 23180019
[TBL] [Abstract][Full Text] [Related]
12. Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms.
Kleinberger I; Sanders E; Staes K; Van Troys M; Hirano S; Hochepied T; Lemeire K; Martens L; Ampe C; van Roy F
BMC Cancer; 2022 Apr; 22(1):451. PubMed ID: 35468745
[TBL] [Abstract][Full Text] [Related]
13. HOTAIR Induces Methylation of PCDH10, a Tumor Suppressor Gene, by Regulating DNMT1 and Sponging with miR-148b in Gastric Adenocarcinoma.
Seo SI; Yoon JH; Byun HJ; Lee SK
Yonsei Med J; 2021 Feb; 62(2):118-128. PubMed ID: 33527791
[TBL] [Abstract][Full Text] [Related]
14. Role of PCDH10 and its hypermethylation in human gastric cancer.
Li Z; Chim JC; Yang M; Ye J; Wong BC; Qiao L
Biochim Biophys Acta; 2012 Feb; 1823(2):298-305. PubMed ID: 22206871
[TBL] [Abstract][Full Text] [Related]
15. Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma.
Li Y; Yang ZS; Song JJ; Liu Q; Chen JB
Int J Mol Med; 2012 Apr; 29(4):704-10. PubMed ID: 22245948
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
[TBL] [Abstract][Full Text] [Related]
18. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
Qiu C; Bu X; Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
[TBL] [Abstract][Full Text] [Related]
19. SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas.
Waha A; Koch A; Hartmann W; Milde U; Felsberg J; Hübner A; Mikeska T; Goodyer CG; Sörensen N; Lindberg I; Wiestler OD; Pietsch T; Waha A
Oncogene; 2007 Aug; 26(38):5662-8. PubMed ID: 17334394
[TBL] [Abstract][Full Text] [Related]
20. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]